The aim of our study was to estimate the surface expressions of CD95 (APO-1/Fas) antigen and the intracellular expressions of anti-apoptotic protein Bcl-2 and pro-apoptotic protein Bax in CD4 pre-eclampsia in comparison with healthy pregnant women in the third trimester of physiological pregnancy. Twenty-four women with pre-eclampsia and 20 normal third trimester pregnant women were included in the study. The lymphocytes were isolated from peripheral blood samples and labeled with monoclonal antibodies. The expressions of surface antigens and intracellular proteins were estimated using flow cytometry. 
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Introduction
Pre-eclampsia (PE) is a common obstetric syndrome affecting about 5-10% of pregnant women [1] . The etiology and pathogenesis of this syndrome are not fully understood. There are many studies describing alterations in the innate and adaptive immune system which may have an influence on the onset of this disorder. It was suggested that the activation of cell-mediated immunity may play the key role in the etiology of pre-eclampsia. It was proposed that inappropriate activation of the immune system can lead to pre-eclampsia [1] [2] [3] [4] .
Regulatory T lymphocytes CD4 + CD25 bright (Tregs) are known to play an important role in the development and maintenance of tolerance in peripheral tissues [5, 6] . It has been demonstrated that Treg cells have a role in induction of transplantation tolerance. They express high level of CD25 (IL-2Rα) as well as cytotoxic T lymphocyte antigen 4 (CTLA-4) and the transcription factor Foxp3 [5] [6] [7] [8] [9] [10] . Maternal immune system responses to fetal antigens play a critical role [11] . There is some evidence that T regulatory lymphocytes (Treg cells) play an essential role in controlling and preventing fetal rejection. It was suggested that high levels of Treg cells are extremely important for successful pregnancy [12] [13] [14] [15] . Furthermore, was observed that the populations of peripheral blood and decidual Treg cells are reduced in pre-eclampsia [16] [17] [18] [19] . On the other hand, there were reports that the numbers of peripheral blood Tregs were similar in pre-eclampsia and normal pregnancy [20, 21] . However, it should be taken into account that in those studies the sample numbers were small or the authors estimated CD4 + CD25 + T cells, and they did not evaluate CD4 + CD25 high Treg cells [20, 21] .
Treg cells cooperate with CD8 + CD28 − T lymphocytes which have also a regulatory capacity [22] .
On the other hand, the expressions of CD28 antigens on CD8 + T cells enhance a T cell activation which may lead to immune responses at the fetal-maternal interface [23] . Apoptosis (programmed cell death) is an important immunoregulatory mechanism for maintaining homeostasis in the immune system. There are a few pathways controlling programmed cell death. The protein Bcl-2 is one of the factors which regulates apoptosis [24, 25] . In humans the family of apoptotic proteins consists of more than 15 members divided into two groups: anti-apoptotic and pro-apoptotic proteins. The proteins: Bcl-2 and Bcl-xLong are characterized as anti-apoptotic proteins thus preventing cell death. The proteins: Bax, Bak, Bad, Bcl-xShort and Bid are known as pro-apoptotic proteins [24, 25] . Activated lymphocytes are removed by Fas/FasL mechanism called activation induced cell death (AICD) [26, 27] . The molecule CD95 (APO-1/Fas) is a surface antigen detectable on activated lymphocytes. Thus, activated lymphocytes may be able to undergo Fas/Fas-L-mediated apoptosis process independently of the Bcl-2 protein family. The antigen CD95 (APO-1/Fas) belongs to the tumor necrosis factor-receptor family (TNF-R).
It was reported recently that the proportion of peripheral blood Treg cells decreases in preeclampsia, but it is unclear why Treg cells decrease [16] [17] [18] [19] .
The aim of our study was to evaluate the levels of CD4 
Results and Discussion
The population of CD4 There were no significant differences in the percentages of CD4 Tables 1 and 2 . Tables 1 and 2 . The percentages of peripheral blood CD8 + CD28 + T cells did not differ in the group of patients with pre-eclampsia when compared to the healthy pregnant women. However, the MFI of CD28 antigen on CD8 + T cells was significantly higher in the group of patients with pre-eclampsia when compared to the control group (p < 0.001). The results are presented in Tables 1 and 2 . During physiological pregnancy there are a lot of alterations in the maternal immune system which prevent an inappropriate response against fetal antigens. Many studies confirmed the theory concerning "Th2 phenomenon", which claimed that during normal pregnancy there is a predominance of Th2 over Th1 type immunity [28] . In the following years "Th2 phenomenon" was revised [29] . In recent studies, it was hypothesized that Treg cells play a crucial role in the maternal tolerance to fetal antigens. This is possible because of their capacity to regulate the activation of allo-reactive T cells [12] [13] [14] [15] . It was observed that normal human pregnancy is associated with the expansion of Treg cells [12] [13] [14] [15] . On the other hand, in the cases of patients with pre-eclampsia decreased levels of Treg cells were found [16] [17] [18] [19] .
Although the factors regulating CD4 subset [30] . It was observed that the concentrations of estrogens are lower in pre-eclampsia when compared to physiological pregnancy [31] . Therefore, it seems possible that the population of Treg cells is decreased in that mechanism in pre-eclampsia. On the other hand, it has been observed that in pre-eclampsia the production of Interleukin-1β (IL-1β) and Interleukin-6 (IL-6) is increased [32] . It is known that the secretion of IL-6, which is a pro-inflammatory cytokine, suppresses the protective immunoregulatory properties of CD4 + CD25 + Treg cells [33] . It seems possible that the increased levels of IL-6 in pre-eclampsia can suppress the expansion of Treg cells in this syndrome.
It has been shown in recent studies that Th17 cells, which induce inflammatory response and Treg cells, which have regulatory properties are developmentally linked [34] . Interleukin-1β and IL-6 induce the differentiation of naïve T cells into Th17 cells, and these cytokines could induce the development of Th17 cells from Treg cells [34, 35] . Transforming growth factor-β (TGF-β) is known to drive the differentiation of Treg cells and to inhibit the differentiation of Th17 cells [36] . In pre-eclampsia the differentiation of Treg cells might be decreased resulting in small numbers of Tregs because of elevated levels of soluble endoglin, which is known to inhibit the TGF-β signalling [37] . In fact, Santner-Nanan et al. reported in their study that the population of Th17 cells is increased and the population of Treg cells is decreased in pre-eclampsia [18] .
Finally, the deficit of Treg cells in pre-eclampsia might be explained by the susceptibility to apoptosis in Treg cells. Fas/FasL-mediated apoptosis seems to be the most important mechanism to keep appropriate balance during pregnancy. Normally, anti-apoptotic protein Bcl-2 remains unchanged during normal pregnancy [37] .
It has been noticed that the induction of Fas/Fas-L mechanism can lead to the depletion of Treg lymphocytes [30] . It was found that APO-1/Fas (CD95) antigen is highly expressed on CD4 + CD25 + FoxP3 + Treg cells. Treg cells are highly susceptible to the ligand for CD95 (CD95L), but not to T cell receptor mediated cell death [38] . The family of Bcl-2 protein is composed of both pro-and anti-apoptotic proteins. It has been suggested that progesterone modulates the expressions of Bcl-2 and Bax proteins. Low concentrations of progesterone lead to the down-regulation of Bax protein and increased levels of Bcl-2 protein [38] . The protein Bcl-2 is described as an inhibitor of programmed cell death, it down-regulates cytochrome c mitochondrial release notably by impairing the pro-apoptotic function of Bax protein. In contrast, the protein Bax releases cytochrome c from mitochondria which induces apoptosis through the activation of caspases 3, 6, 7, 9 [24, 25] .
In our study we observed the deficit of CD4 In the present study we also evaluated the expressions of CD28 antigen on peripheral blood CD8 + T lymphocytes of patients with pre-eclampsia and normal third trimester pregnant women. The antigen CD28 is thought to be a co-stimulatory molecule which may enhance T-cells activation [22, 39] .
We studied the percentages of T CD8 + CD28 + lymphocytes but we did not find any differences between the populations of these cells in normal pregnancy and pre-eclampsia. However, the mean fluorescence intensity of CD28 antigen on T CD8 + lymphocytes was significantly higher in 
Material and Methods

Patients
The patients participating in this study were admitted to the Department of Obstetrics and Perinatology, Medical University of Lublin, Poland. The study group consisted of 24 pregnant women with pre-eclampsia. They were admitted to the hospital because of the symptoms of the disease but not because of signs of labour. Pre-eclamptic patients were classified according to the regulations of the Committee on Terminology of American College of Obstetricians and Gynecologists. Pre-eclampsia was characterized by blood pressure of at least 140/90 mmHg and proteinuria above 0.3 g/24 h. None of the pre-eclamptic patients was affected by preexisting clinical disorders, such as: chronic hypertension, renal diseases before pregnancy, and none of the pregnancies was complicated by preterm labor or chorioamnionitis. The control group included 20 healthy normotensive pregnant women in the third trimester of normal pregnancy. They were recruited from the outpatient clinic. All pregnancies from the study and control groups were single. The patients from the study and control groups were not in active labor. The characteristics of the study and control groups are presented in Table 3 . The study design was accepted by the local Ethics Committee. Informed consent for peripheral blood sampling was obtained from the patients. Table 3 . The clinical characteristics of patients with pre-eclampsia (study group) and healthy normotensive women in the third trimester of uncomplicated pregnancy (control group).
Study group mean ± SD n = 24
Control group mean ± SD n = 20 Significance (p) 
Blood Sampling and Cell Preparation
Twenty milliliters of blood from both pre-eclamptic patients and normal third trimester pregnant women were taken by venipuncture and collected in sterile heparinized tubes. Blood samples from the patients with pre-eclampsia were taken before any treatment, such as: the administration of antenatal steroids or antihypertensive drugs.
Isolation of Peripheral Blood Cells
Peripheral blood mononuclear cells (PBMCs) were separated by gradient centrifugation on the lymphocyte separation medium, Lymphoprep (Nycomed, Torshov, Norway). They were centrifuged for 30 min at 600× g at 4 °C, collected from the interface with a Pasteur pipette and washed twice by centrifugation for 5 min at 250 g at 4 °C in 2 mL of the buffer containing phosphate-buffered saline (PBS; Serum and Vaccine Factory, Biomed, Lublin, Poland) with 2% FCS (Fetal Calf Serum, GibcoBRL, Paisley, UK) and the total numbers of cells were determined using the microscope.
Phenotyping of T Cells
The cell surface and intracellular antigens were determined on the fresh cells at the time of the sample submission. The cells were stained according to the manufacturer's protocols. 
Statistical Analysis
Statistical differences between groups were estimated using a standard non-parametric test (Mann-Whitney U-test). The results were presented as a median and interquartile ranges. Differences were defined as statistically significant at the level of p < 0.05. Statistica 7.0 software (StatSoft Poland, Krakow, Poland) was applied to statistical analysis. 
Conclusions
The obtained results suggest that the deficit of CD4 
